lymphoid malignancies

Related by string. * Lymphoid : lymphoid tumors currently . lymphoid cells . associated lymphoid tissue . lymphoid blast . lymphoid organs . neck lymphoid . acute lymphoid leukemia / Malignancies : gynecological malignancies . hematologic malignancies . Hematologic Malignancies . hematological malignancies . haematological malignancies . gynecologic malignancies * *

Related by context. Frequent words. (Click for all words.) 72 refractory chronic lymphocytic 71 myeloproliferative disorders 70 multiple myeloma MM 68 HER2 positive metastatic breast 68 targeting CD# 68 heavily pretreated 68 relapsed refractory multiple myeloma 68 Epratuzumab 67 metastatic renal cell carcinoma 67 Panzem R 67 leukemia CLL 66 androgen independent 66 metastatic castration resistant 66 leukemia ALL 66 gastrointestinal stromal tumors GIST 66 ixabepilone 66 ovarian breast 66 SAR# [004] 65 recurrent glioblastoma 65 Initiate Phase 65 Daclizumab 65 INCB# [001] 65 liposomal formulation 65 colorectal carcinoma 65 xenograft models 65 PXD# 65 CD# expressing 65 Vandetanib 65 axitinib 65 Traficet EN 65 pancreatic neuroendocrine tumors 65 bendamustine 65 Clofarabine 65 nosocomial pneumonia 65 leukaemias 65 Pivotal Phase III 64 Lenalidomide 64 gastrointestinal stromal tumors 64 IMC #B 64 FLT3 64 forodesine 64 Chronic Lymphocytic Leukemia 64 APOPTONE 64 Recombinant Human 64 metastatic hormone refractory 64 Phase Ib II 64 mRCC 64 Metastatic Melanoma 64 K ras 64 Voreloxin 64 hepatocellular cancer 64 tanespimycin 64 secondary hyperparathyroidism 64 malignant pleural mesothelioma 64 R sorafenib tablets 64 carcinoid tumors 64 vorinostat 64 IMC A# 64 deforolimus 64 ThermoDox R 64 luteinizing hormone releasing 64 Chronic Heart Failure 64 enzastaurin 64 Golimumab 64 Azedra 64 hypoxia inducible factor 64 cell acute lymphoblastic 64 MORAb 63 KRAS mutations 63 Irinotecan 63 Pivotal Trial 63 hepatocellular carcinoma HCC 63 medullary thyroid cancer 63 pertuzumab 63 relapsed refractory 63 Amrubicin 63 CR# vcMMAE 63 pheochromocytoma 63 EGFR mutations 63 PsA 63 KRAS wild 63 Alemtuzumab 63 allogeneic stem cell 63 HGS ETR1 63 Drug Candidate 63 murine model 63 pancreatic NET 63 PEG SN# 63 Idiopathic Pulmonary Fibrosis 63 EGFR expressing mCRC 63 lymphoma CTCL 63 immunomodulating 63 hematological malignancies 63 Acute Myeloid Leukemia AML 63 neovascular age 63 Pivotal Phase 63 EGFR inhibitors 63 Monoclonal Antibody 63 ATL# [001] 62 primary hypercholesterolemia 62 B CLL

Back to home page